Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2009 Jul;33(7):1502-8.
doi: 10.1007/s00268-009-0066-7.

Total pelvic exenteration for primary and recurrent malignancies

F T J Ferenschild  1 , M Vermaas, C Verhoef, A C Ansink, W J Kirkels, A M M Eggermont, J H W de Wilt
Affiliations
Comparative Study

Total pelvic exenteration for primary and recurrent malignancies

F T J Ferenschild et al. World J Surg. 2009 Jul.

Abstract

Introduction: Complete resection is the most important prognostic factor in surgery for pelvic tumors. In locally advanced and recurrent pelvic malignancies, radical margins are sometimes difficult to obtain because of close relation to or growth in adjacent organs/structures. Total pelvic exenteration (TPE) is an exenterative operation for these advanced tumors and involves en bloc resection of the rectum, bladder, and internal genital organs (prostate/seminal vesicles or uterus, ovaries and/or vagina).

Methods: Between 1994 and 2008, a TPE was performed in 69 patients with pelvic cancer; 48 with rectal cancer (32 primary and 16 recurrent), 14 with cervical cancer (1 primary and 13 recurrent), 5 with sarcoma (3 primary and 2 recurrent), 1 with primary vaginal, and 1 with recurrent endometrial carcinoma. Ten patients were treated with neoadjuvant chemotherapy and 66 patients with preoperative radiotherapy to induce down-staging. Eighteen patients received IORT because of an incomplete or marginal complete resection.

Results: The median follow-up was 43 (range, 1-196) months. Median duration of surgery was 448 (range, 300-670) minutes, median blood loss was 6,300 (range, 750-21,000) ml, and hospitalization was 17 (range, 4-65) days. Overall major and minor complication rates were 34% and 57%, respectively. The in-hospital mortality rate was 1%. A complete resection was possible in 75% of all patients, a microscopically incomplete resection (R1) in 16%, and a macroscopically incomplete resection (R2) in 9%. Five-year local control for primary locally advanced rectal cancer, recurrent rectal cancer, and cervical cancer was 89%, 38%, and 64%, respectively. Overall survival after 5 years for primary locally advanced rectal cancer, recurrent rectal cancer, and cervical cancer was 66%, 8%, and 45%.

Conclusions: Total pelvic exenteration is accompanied with considerable morbidity, but good local control and acceptable overall survival justifies the use of this extensive surgical technique in most patients, especially patients with primary locally advanced rectal cancer and recurrent cervical cancer.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Kaplan–Meier curve for local control
Fig. 2
Fig. 2
Kaplan–Meier curve for overall survival
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1007/s10350-006-0651-x', 'is_inner': False, 'url': 'https://doi.org/10.1007/s10350-006-0651-x'}, {'type': 'PubMed', 'value': '16912909', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16912909/'}]}
    2. Ferenschild FT, Vermaas M, Nuyttens JJ et al (2006) Value of intraoperative radiotherapy in locally advanced rectal cancer. Dis Colon Rectum 49:1257–1265 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1007/s10350-004-0891-6', 'is_inner': False, 'url': 'https://doi.org/10.1007/s10350-004-0891-6'}, {'type': 'PubMed', 'value': '15785886', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15785886/'}]}
    2. Vermaas M, Ferenschild FT, Nuyttens JJ et al (2005) Preoperative radiotherapy improves outcome in recurrent rectal cancer. Dis Colon Rectum 48:918–928 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/j.ejso.2006.09.021', 'is_inner': False, 'url': 'https://doi.org/10.1016/j.ejso.2006.09.021'}, {'type': 'PubMed', 'value': '17071043', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17071043/'}]}
    2. Vermaas M, Ferenschild FT, Verhoef C et al (2007) Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol 33:452–458 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '14782163', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/14782163/'}]}
    2. Bricker EM (1950) Bladder substitution after pelvic evisceration. Surg Clin N Am 30:1511 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/j.ejso.2003.08.008', 'is_inner': False, 'url': 'https://doi.org/10.1016/j.ejso.2003.08.008'}, {'type': 'PubMed', 'value': '14602493', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/14602493/'}]}
    2. Kecmanovic DM, Pavlov MJ, Kovacevic PA, Sepetkovski AV, Ceranic MS, Stamenkovic AB (2003) Management of advanced pelvic cancer by exenteration. Eur J Surg Oncol 29:743–746 - PubMed

Publication types

MeSH terms